KD is characterized by systemic vasculitis of mid-sized arteries, and coronary arteritis that sometimes results in cardiac events such as ischemia, myocardial infarction (MI), or sudden death. More than 6,000 children (58% are male, and 55% are under 2 y of age) in Japan develop KD annually. Despite Ig therapy (IVIG), severe CAD sequelae such as CA dilation (5.05% boys, 3.6% girls), CA aneurysm (3.15% boys, 1.60% girls), CA narrowing (0.11% both in boys and girls), and MI (0.05% boys, 0.07% girls) occur 1 mo after KD onset (1) . The etiology of KD remains unknown, although hypercytokinemia and hyperchemokinemia occur during acute KD (2, 3) , and most KD symptoms can be explained by this pathophysiology. Vasoactive factors are also considered to be involved in KD and contribute to vascular remodeling, especially in patients who progress to CAD.
Many vasoactive factors, such as Ag II, endothelin (ET), and nitric oxide (NO), participate in vascular remodeling [review (4) ]. RAS is thought to be involved in coronary thrombosis, vasoconstriction, and smooth muscle cell proliferation as well as in myocardial and coronary vascular cell remodeling. High plasma ACE levels increase arterial wall thickness (5) . ACE activities also interfere with coronary vasomotion (6) and ventricular remodeling (7) . Individuals carrying the D allele in ACE I/D polymorphism have higher ACE activities in the blood (8, 9) , and Cambien et al. (10) discovered that the D allele is a risk factor for MI. However, several subsequent studies of the ACE I/D and AT1R 1166A/C polymorphisms (11) (12) (13) (14) have yielded conflicting results (15, 16) . On the other hand, the results of a mega-clinical study (17, 18) have proven that ACE and AT1R antagonists have positive effects against cardiovascular events. How ACE polymorphisms affect CAD remains controversial, but RAS is closely involved with CAD in adults.
Adult CAD and that caused by KD histologically differ. Adult CAD is mainly caused by atherosclerotic lesions, whereas the characteristic histologic feature of CAD caused by KD is severe intimal thickening (19, 20) . In addition, AT1R activation, the main receptor of AgII, promotes proliferation, migration, hypertrophy, and the production of reactive oxygen species in vascular smooth muscle cells (VSMC) (21, 22) . Thus, RAS should be closely associated with vascular remodeling in KD. Few studies have addressed renin/angiotensin in KD. Takeuchi et al. (23) found that the ACE I/D polymorphism genotype I/I was a risk factor for CA aneurysm in a study of 36 patients with KD. Falcini et al. (24) reported that ACE activities are rather attenuated during the acute phase of KD. The present study investigates whether the ACE I/D and AT1R 1166A/C polymorphisms are associated with CA lesions in a relatively large cohort of patients with KD and examines ACE activities during the convalescent phase of KD, when the CA is being remodeled.
MATERIALS AND METHODS

Subjects
We obtained written informed consent from the parents of 281 Japanese children with KD (176 boys and 105 girls, age 4.69 Ϯ 0.40 y) to participate in this study, which conformed to the guidelines of the Nippon Medical School Ethics Committee. The patients were recruited from several Japanese medical centers. The patients included those recently diagnosed with KD between 1999 and 2003 (n ϭ 183), and those who had been under clinical follow-up since 1984 (n ϭ 98). Among them, 10 (included 2 ischemia patients) were from the Kinki area, 12 (included 1 ischemia patient) were from Kyushu, and the remainder were from the Kanto area of Japan. All the patients received aspirin, 276 received IVIG, and all those who had developed severe CA stenosis with myocardial ischemia received IVIG. Echocardiography screenings were performed at least twice a week within 1 mo of the onset of KD. When the CA became dilated to over 1.5-fold the size of the adjacent CA at 1 mo after KD onset, coronary angiography was performed. Myocardial ischemia was diagnosed by treadmill exercise or dobutamine stress electrocardiography, and dobutamine stress 99m Tc tetrofosmin scintigraphy (25, 26) . Severe CA stenosis with myocardial ischemia was defined as over 90% CA stenosis, and positive electrocardiographic or scintigraphic findings (25, 26) . We compared data from two groups of KD patients: group N (n ϭ 246, age 3.54 Ϯ 4.42 y), no myocardial ischemia; group I (n ϭ 35, age 10.97 Ϯ 1.12 y), severe CA stenosis with myocardial ischemia.
The controls consisted of 147 healthy adult volunteers (male, 69; female, 78; age 26.90 Ϯ 0.57 y) from the Kanto area of Japan.
Methods
Genotyping by PCR. Genomic DNA was extracted from blood samples using a DNA blood mini kit (QIAGEN, Valencia, CA). We amplified DNA sequences that included the ACE I/D and AT1R 1166A/C polymorphisms using PCR. The ACE I/D polymorphism was detected using the primers, 5'CCA GCC CTC CCA TGC CCA TAA C3' and 5'GAG AGA CTC AAG CAC GCC CCT CAC3', which were designed based on a reported nucleotide sequence (GenBank AC113554), and which correspond to positions 117033 and 117332, respectively. The PCR proceeded in an Applied Biosystems (Foster City, CA) 9700 PCR system using 10 ng DNA, 5 pM of each primer, 0.25 mM dNTP, 1.5 mM MgCl 2 , and 1.5 U of Taq polymerase (Takara Bio Inc., Ohtsu, Japan) in a total volume of 25 L. Amplification consisted of five PCR cycles of 94°C for 30 s, 72°C for 60 s, and five cycles of 94°C for 30 s and 70°C for 60 s followed by 25 cycles of 94°C for 30 s and 68°C for 60 s. The PCR products corresponding to the I and D alleles migrated at 610 and 323 bp, respectively on 1.5% agarose gels. To exclude mistyping of the D allele, independent PCR proceeded using insertion-specific primers, following the procedure of Lindpaintner et al. (13) . The AT1R 1166A/C polymorphism was detected using the primers 5'GCA CAA TGC TTG TAG CCA AAG TCA C3' and 5'TCC GAG CAG CCG TCA TCT GTC TA3' according to the AT1R gene sequence (GenBank AF245699), which correspond to positions 49311 and 50182, respectively. The PCR reaction proceeded in the same manner as that for the ACE I/D polymorphism. The PCR products were digested with the restriction enzyme DdeI overnight at 37°C, and resolved by electrophoresis on 4% agarose gels into 605 and 289 bp bands for the A allele. When the C allele was present, the 289 bp band was further digested into 146 and 143 bp bands.
ACE activity assay. Plasma samples were obtained from the KD patients before and after IVIG and during the convalescent phase (2 mo after KD onset), and control samples were immediately stored at Ϫ80°C.
ACE activities were measured according to the colorimetric procedure of Kasahara and Ashihara (27) .
Statistics. We calculated odds ratios to estimate the relative risk of severe CA stenosis with myocardial ischemia in patients with the ACE D and AT1R C allele genotypes. The results were analyzed using logistic regression models and the software StatView 5.0 (SAS Institute Inc., Cary, NC). The calculated confidence interval (CI) was 95%. Statistical significance was confirmed by the 2 test, and when the predicted frequencies were below 10, Fisher's exact test confirmed the findings. A 598 value of p Ͻ 0.05 was considered significant. Statistical real numbers are expressed as means Ϯ SE. ACE activity was compared by one-way ANOVA. Significant differences were further analyzed using the posthoc test. Table 2 ). Significant differences among the genotypes between two groups were undetectable. However, when the genotype was analyzed with respect to the presence of the D allele between groups N and I, the frequency of the D allele (I/D ϩ D/D) tended to be higher in group I (71.4% versus 55.6%, p ϭ 0.077; odds ratio, 2.00; 95% CI, 0.92-4.34) ( Table 2) .
RESULTS
ACE
AT1R 1166A/C polymorphism. We obtained informative results from 273 of the 281 KD patients, and from 138 of the 147 controls. Because the C/C genotype polymorphism was found only once both in control and in KD patients, we analyzed the genotype with respect to the presence of the C allele. The frequency of this allele was as follows: in controls: A/A, 85.5% (n ϭ 118); A/CϩC/C, 14.5% (n ϭ 20); in KD patients: A/A, 83.5% (n ϭ 228); A/CϩC/C, 16.5% (n ϭ 45) ( Table 1 ). The genotypes did not significantly differ between controls and KD patients. Genotypes between the KD groups were Group N: A/A, 85.3% (n ϭ 203); A/CϩC/C, 14.7% (n ϭ 35); Group I: A/A, 71.4% (n ϭ 25); A/CϩC/C, 28.6% (n ϭ 10) ( Table 2 ). The frequency of the C allele (A/CϩC/C) became significantly higher in group I than in group N (28.6% versus 14.7%, p ϭ 0.039; odds ratio, 2.32; 95% CI, 1.03-5.25) ( Table  2) .
Effect of D and C alleles of ACE I/D and AT1R 1166A/C polymorphisms, respectively. We examined whether patients with both a D and a C allele in the ACE I/D and AT1R 1166A/C polymorphisms, respectively, had an increased risk of developing severe CA stenosis with myocardial ischemia.
The number of patients with either or both of these alleles was considerably higher in group I than in group N, compared with those who had neither allele (61.6% versus 80.0%, p ϭ 0.038; odds ratio, 2.71; 95%CI, 1.05-6.99) ( Table 3) . That means both the D and C alleles are associated with the development of severe stenosis with ischemia in patients with KD. On the other hand, when we compared the number of patients with both of these alleles to those with neither or either one of these alleles, the risk of severe stenosis with ischemia tended to be higher in those who had both alleles (odds ratio, 2.71; p ϭ 0.061). That is, having both the D and C alleles increased the risk for severe stenosis with ischemia in KD. Although not statistically significant, the risk of developing severe stenosis with ischemia might be high in patients with both of these alleles.
Serum ACE activities during acute and convalescent phases of KD. To evaluate how ACE activities change during the KD phase, we serially measured ACE activities in seven controls and in eight KD patients before and after IVIG and at the convalescent phase (2 mo after KD onset). Eight representative KD patients (four boys and four girls, age 2.5 Ϯ 0.6 y), whose clinical KD course was typical, were all good responders to IVIG and echocardiography did not show CA involvement. Their ACE I/D genotypes were I/I in two and I/D in six. The controls were two females and five males, age 25.6 Ϯ 0.8 y. Their ACE genotypes were I/I in two and I/D in five. The results were as follows: controls: 12.73 Ϯ 1.24; KD pre-IVIG: 8.76 Ϯ 1.49; KD post-IVIG: 13.46 Ϯ 1.11; KD convalescent: 16.84 Ϯ 5.70 IU/L. One-way ANOVA showed a significant difference between the groups (p Ͻ 0.01). The ACE activity of the KD convalescent phase was significantly increased compared with that of KD before and after IVIG (p Ͻ 0.001 and p ϭ 0.039, respectively) (Fig. 1) . (28) suggested that the D allele could be a risk factor for CA stent restenosis. Whereas the findings of other large clinical studies (13, 29) have confirmed a negative correlation between CAD and ACE I/D polymorphism, Gardemann et al. (14) confirmed in a study of 2267 younger individuals that the ACE D allele increases the risk of CAD. Because the incidence of CAD is also affected by age and lifestyle, we supposed that the ACE I/D polymorphism contributes more to effects in younger individuals. Renin/ angiotensin inhibition significantly attenuates unfavorable myocardial and vascular remodeling in rodents (30) but not in humans (29) . Several factors can explain this disparity between rodents and humans, such as species differences and dose of renin/angiotensin antagonists. Moreover, there are basic histologic differences between adult CAD and CAD caused by KD. Atherosclerotic findings, such as macrophage foam cells, atheroma, and plaque formation, are mainly found in adult CAD. Thrombus formation followed by plaque rupture is thought to be one of the key causes of ischemic heart disease. On the other hand, CAD caused by KD is characterized by intimal thickening (19, 20) and myocardial ischemia because CA narrowing is mainly induced by intimal hyperplasia (26) . AgII promotes vascular SMC proliferation and pro-inflammatory cytokine and growth factor production through AT1R activation (21, 22) . These positive vascular remodeling effects of AgII should lead to intimal thickness. Thus, RAS probably contributes more to CAD that arises due to KD.
The present study found that the frequencies of the ACE and AT1R genotypes in controls and KD patients were similar to those reported for the normal Japanese population (31, 32) . These facts suggest that the ACE and AT1R genotypes are not involved in the onset of KD.
Serum ACE activity during acute KD was significantly attenuated and recovered to even higher levels than controls during the convalescent phase. In addition, the ACE I/D polymorphism D allele, which increases ACE activity (8, 9) , was prevalent in KD patients with severe CA stenosis and ischemia. Our results imply that a higher renin/angiotensin state is closely associated with intimal hyperplasia and with the development of severe CA ischemia. On the other hand, the C allele of the AT1R 1166A/C polymorphism is associated with aortic stiffness (33, 34) , hypertension (35, 36) , and CA vascular tone (37, 38) . In addition, a combination of the ACE D and AT1R C alleles enhances the risk of CAD (15, 16) . Our results confirmed that having both of the ACE D and AT1R C alleles increases the risk of CA stenosis in children with KD.
Harada et al. (39) proved that neointima is formed after aortic balloon injury in the AT1Ra knockout mouse. This means that signal transduction via the AT1Ra receptor is not always necessary for neointimal formation. However, they also confirmed that the amount of AT1R mRNA significantly increases after injury, and that an AT1R antagonist decreases neointima formation in the wild-type mouse. AgII signaling mediated by AT1R might not be essential for the development of neointimal formation, although AT1R-mediated signaling can modify neointimal formation and AgII is a useful means of blocking vascular remodeling. This also suggests that AgII blockades are useful for treating CA injury such as that associated with KD. We probed the higher risk of myocardial ischemia in patients with KD carrying the ACE D and AT1R C alleles. We believe that patients with these polymorphisms should be carefully monitored and that AgII blockades should be considered for treating patients with KD.
Study limitations. We enrolled 147 controls and 281 patients with KD, the latter of which is a relatively small number for this type of study. The ischemia group consisted of 35 patients, which was also a small cohort. However, the prevalence of KD onset is only about 7000 per year in Japan, and KD patients who progress to ischemic heart disease account for Ͻ0.1% of those with the disease. Although several centers participated in this study, collecting a sufficient number of patients with KD was difficult. In addition, we did not compare other CAD risk factors, such as serum cholesterol or serum inflammatory substances that are closely correlated to CAD in adults. Because the ischemia group was young (10.97 Ϯ 1.12 y), we believe that CAD risk factors did not significantly affect this study. 
